NASDAQ: VTGNVistagen Therapeutics Inc Stock Ownership - Who owns Vistagen Therapeutics?
Insider buying vs selling
Have Vistagen Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER | 2024-12-31 | 2,592 | $2.51 | $6.50kBuy |
| Joshua S. Prince | Chief Operating Officer | 2024-12-31 | 3,310 | $2.51 | $8.30kBuy |
| Reid G. Adler | CHF CORP DEVEL OFF GEN COUNS | 2024-06-28 | 4,854 | $2.96 | $14.36kBuy |
| Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER | 2024-06-28 | 3,592 | $2.96 | $10.63kBuy |
| Joshua S. Prince | Chief Operating Officer | 2024-06-28 | 2,671 | $2.96 | $7.90kBuy |
| Shawn Singh | CHIEF EXECUTIVE OFFICER | 2024-06-28 | 4,854 | $2.96 | $14.36kBuy |
VTGN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VTGN insiders and whales buy or sell their stock.
VTGN Shareholders
What type of owners hold Vistagen Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Venrock Healthcare Capital Partners II LP | 71.50% | 20,637,286 | $43.54M | Insider |
| Holding Co Cato | 11.47% | 3,310,836 | $6.99M | Insider |
| Tcg Crossover Management LLC | 9.27% | 2,676,580 | $5.65M | Institution |
| Stempoint Capital LP | 8.07% | 2,328,492 | $4.91M | Institution |
| Vanguard Group Inc | 7.00% | 2,020,351 | $4.26M | Institution |
| Nantahala Capital Management LLC | 6.87% | 1,981,980 | $4.18M | Institution |
| Commodore Capital LP | 5.46% | 1,575,000 | $3.32M | Institution |
| Platinum Long Term Growth VII LLC | 5.40% | 1,558,862 | $3.29M | Insider |
| Sphera Funds Management Ltd | 2.80% | 808,550 | $1.71M | Institution |
| Commodore Capital LP | 2.77% | 799,244 | $1.69M | Insider |
VTGN vs Biotech Stocks
Vistagen Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.